Biogen drops controversial Alzheimer’s drug Aduhelm to focus on Leqembi, experimental treatments
Biogen said its decision to drop Aduhelm, which had a polarizing approval and launch, was "not related to any safety or efficacy concerns."
Starbucks’ earnings report was weak — but Wall Street expected worse
Starbucks executives said the challenges faced by the company are "transitory."
Walmart plans to add more than 150 large-format stores across the U.S.
Walmart already has a massive footprint, with more than 4,600 stores across the country.
Adidas won’t write off remaining Yeezy inventory, plans to sell ‘at least’ at cost
Adidas won't write off the majority of its unsold Yeezy inventory after its breakup with Ye, the rapper formerly known as Kanye West, over antisemitism.
PGA Tour secures up to $3 billion from U.S. investors as LIV Golf merger hangs in the balance
Strategic Sports Group's investment in the PGA Tour comes as the professional golf organization's merger with the Saudi-backed LIV Golf is up in the air.
Samsung Electronics’ semiconductor business reports record annual loss
Samsung Electronics released its fourth-quarter earnings report on Wednesday.
H&M shares tumble 12% after weaker sales and surprise CEO exit
"It has been very demanding at times for me personally," outgoing CEO Helena Helmersson said.
Novo Nordisk hits $500 billion in market value as it flags soaring demand for Wegovy, Ozempic
Novo Nordisk, Europe's largest company by market capitalization, on Wednesday reported better-than-expected 2023 earnings.
Boeing holds off on 2024 guidance as CEO says ‘we caused’ 737 Max 9 midair blowout
Boeing did not provide a 2024 outlook, weeks after a fuselage panel blew out midflight on a nearly new 737 Max 9 on Jan. 5.